Citigroup
WX

Citigroup’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Citigroup’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-134,779
Closed -$5.82M – 8217
2015
Q3 		$5.82M Sell
134,779
-23,100
-15% -$975K 0.01% 1540
2015
Q2 		$6.67M Buy
157,879
+151,670
+2,443% +$6.4M 0.01% 1504
2015
Q1 		$240K Buy
6,209
+1,659
+36% +$63.9K ﹤0.01% 4366
2014
Q4 		$153K Buy
4,550
+184
+4% +$6.5K ﹤0.01% 4906
2014
Q3 		$153K Sell
4,366
-52
-1% -$1.78K ﹤0.01% 4426
2014
Q2 		$145K Buy
4,418
+605
+16% +$20.7K ﹤0.01% 4389
2014
Q1 		$141K Sell
3,813
-528
-12% -$19.4K ﹤0.01% 4674
2013
Q4 		$167K Buy
4,341
+1,692
+64% +$53.4K ﹤0.01% 4816
2013
Q3 		$73K Sell
2,649
-4,028
-60% -$95.4K ﹤0.01% 4981
2013
Q2 		$140K Buy
+6,677
New +$130K ﹤0.01% 4576

Other funds holding WX

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Citigroup's WX Position: Q4 2015 in Review

Citigroup sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 134,779 shares — an estimated $5.82M sold.

Citigroup first reported a position in WX in Q2 2013 and held it in 10 quarters. The position peaked at $6.67M in Q2 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • Citigroup reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • Citigroup sold 134,779 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $5.82M.
  • Citigroup first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 10 quarters.
  • Citigroup's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $6.67M in Q2 2015.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Citigroup's 13F filing for Q4 2015, filed 12 Feb 2016.